Company DarioHealth Corp.

Equities

DRIO

US23725P2092

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
1.48 USD +0.68% Intraday chart for DarioHealth Corp. +27.59% -13.95%

Business Summary

DarioHealth Corp. is a global digital therapeutics (DTx) company. The Company operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutic interventions. Its platform and suite of solutions delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its products include Dario Blood Pressure Monitoring System and Dario Blood Glucose Monitoring Starter Kit. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows to store all its user readings in the Dario App. Its Dario mobile app is a complete, cloud-based solution for personal chronic condition management.

Number of employees: 285

Sales per Business

USD in Million2022Weight2023Weight Delta
Services
64.3 %
18 64.6 % 13 64.3 % -26.74%
Consumer Hardware
35.7 %
10 35.4 % 7 35.7 % -25.81%

Sales per region

USD in Million2022Weight2023Weight Delta
Global
100.0 %
28 100.0 % 20 100.0 % -26.41%

Managers

Managers TitleAgeSince
Chief Executive Officer 51 12-09-30
Founder - 11-08-10
Director of Finance/CFO 63 15-01-06
President 55 20-01-06
Chief Tech/Sci/R&D Officer - 21-01-31
Compliance Officer - 20-08-31
Chief Tech/Sci/R&D Officer - 20-03-25
Chief Tech/Sci/R&D Officer - 19-01-31
Chief Operating Officer 53 Feb. 14
Investor Relations Contact - 22-06-30

Members of the board

Members of the board TitleAgeSince
Director/Board Member 67 13-11-11
Director/Board Member 60 11-10-26
Chairman 52 18-07-04
Director/Board Member 55 14-11-22
Director/Board Member 63 20-07-01
Chief Executive Officer 51 12-09-30
Director/Board Member 56 23-02-22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 29,442,532 25,080,922 ( 85.19 %) 0 85.19 %
Stock B 0 18,959 0 0

Shareholders

NameEquities%Valuation
Nantahala Capital Management LLC
8.591 %
2,336,753 8.591 % 4 M $
1,912,059 7.029 % 3 M $
Appian Way Asset Management LP
4.862 %
1,322,444 4.862 % 2 M $
1,288,518 4.737 % 2 M $
MORE Investment House Ltd.
4.737 %
1,288,518 4.737 % 2 M $
1,180,813 4.341 % 2 M $
Kershner Trading Americas LLC
3.871 %
1,053,024 3.871 % 2 M $
875,964 3.220 % 1 M $
747,821 2.749 % 1 M $
Vanguard Global Advisers LLC
1.335 %
363,042 1.335 % 555 454 $

Company contact information

DarioHealth Corp.

322 W 57th Street Suite 33B

10019, New York

+

http://www.dariohealth.com
address DarioHealth Corp.(DRIO)
  1. Stock Market
  2. Equities
  3. DRIO Stock
  4. Company DarioHealth Corp.